Literature DB >> 10899085

Estimation of parallel conductance by dual-frequency conductance catheter in mice.

D Georgakopoulos1, D A Kass.   

Abstract

The conductance catheter method has substantially enhanced the characterization of in vivo cardiovascular function in mice. Absolute volume determination requires assessment of parallel conductance (V(p)) offset because of conductivity of structures external to the blood pool. Although such a determination is achievable by hypertonic saline bolus injection, this method poses potential risks to mice because of volume loading and/or contractility changes. We tested another method based on differences between blood and muscle conductances at various catheter excitation frequencies (20 vs. 2 kHz) in 33 open-chest mice. The ratio of mean frequency-dependent signal difference to V(p) derived by hypertonic saline injection was consistent [0.095 +/- 0.01 (SD), n = 11], and both methods were strongly correlated (r(2) = 0.97, P < 0.0001). This correlation persisted when the ratio was prospectively applied to a separate group of animals (n = 12), with a combined regression relation of V(p(DF)) = 1.1 * V(p(Sal)) - 2.5 [where V(p(DF)) is V(p) derived by the dual-frequency method and V(p(Sal)) is V(p) derived by hypertonic saline bolus injection], r(2) = 0.95, standard error of the estimate = 1.1 microl, and mean difference = 0.6 +/- 1.4 microl. Varying V(p(Sal)) in a given animal resulted in parallel changes in V(p(DF)) (multiple regression r(2) = 0.92, P < 0.00001). The dominant source of V(p) in mice was found to be the left ventricular wall itself, since surrounding the heart in the chest with physiological saline or markedly varying right ventricular volumes had a minimal effect on the left ventricular volume signal. On the basis of V(p) and flow probe-derived cardiac output, end-diastolic volume and ejection fraction in normal mice were 28 +/- 3 microl and 81 +/- 6%, respectively, at a heart rate of 622 +/- 28 min(-1). Thus the dual-frequency method and independent flow signal can be used to provide absolute volumes in mice.

Entities:  

Mesh:

Year:  2000        PMID: 10899085     DOI: 10.1152/ajpheart.2000.279.1.H443

Source DB:  PubMed          Journal:  Am J Physiol Heart Circ Physiol        ISSN: 0363-6135            Impact factor:   4.733


  12 in total

1.  Measurement of cardiac function using pressure-volume conductance catheter technique in mice and rats.

Authors:  Pál Pacher; Takahiro Nagayama; Partha Mukhopadhyay; Sándor Bátkai; David A Kass
Journal:  Nat Protoc       Date:  2008       Impact factor: 13.491

2.  Sex-related changes in cardiac function following myocardial infarction in mice.

Authors:  Krystyna M Shioura; David L Geenen; Paul H Goldspink
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2008-06-11       Impact factor: 3.619

3.  Cardiac Pressure-Volume Loop Analysis Using Conductance Catheters in Mice.

Authors:  Dennis Abraham; Lan Mao
Journal:  J Vis Exp       Date:  2015-09-17       Impact factor: 1.355

4.  The in vivo role of p38 MAP kinases in cardiac remodeling and restrictive cardiomyopathy.

Authors:  P Liao; D Georgakopoulos; A Kovacs; M Zheng; D Lerner; H Pu; J Saffitz; K Chien; R P Xiao; D A Kass; Y Wang
Journal:  Proc Natl Acad Sci U S A       Date:  2001-10-02       Impact factor: 11.205

5.  A bio-telemetric device for measurement of left ventricular pressure-volume loops using the admittance technique in conscious, ambulatory rats.

Authors:  Karthik Raghavan; Marc D Feldman; John E Porterfield; Erik R Larson; J Travis Jenkins; Daniel Escobedo; John A Pearce; Jonathan W Valvano
Journal:  Physiol Meas       Date:  2011-05-23       Impact factor: 2.833

6.  Minimal force-frequency modulation of inotropy and relaxation of in situ murine heart.

Authors:  D Georgakopoulos; D Kass
Journal:  J Physiol       Date:  2001-07-15       Impact factor: 5.182

7.  Dynamic correction for parallel conductance, GP, and gain factor, alpha, in invasive murine left ventricular volume measurements.

Authors:  John E Porterfield; Anil T G Kottam; Karthik Raghavan; Daniel Escobedo; James T Jenkins; Erik R Larson; Rodolfo J Treviño; Jonathan W Valvano; John A Pearce; Marc D Feldman
Journal:  J Appl Physiol (1985)       Date:  2009-08-20

8.  Cardiomyocyte cell cycle activation improves cardiac function after myocardial infarction.

Authors:  Rutger J Hassink; Kishore B Pasumarthi; Hidehiro Nakajima; Michael Rubart; Mark H Soonpaa; Aart Brutel de la Rivière; Pieter A Doevendans; Loren J Field
Journal:  Cardiovasc Res       Date:  2007-12-12       Impact factor: 10.787

9.  Expression of a transgene encoding mutant p193/CUL7 preserves cardiac function and limits infarct expansion after myocardial infarction.

Authors:  R J Hassink; H Nakajima; H O Nakajima; P A Doevendans; L J Field
Journal:  Heart       Date:  2009-05-11       Impact factor: 5.994

10.  Chronic Rho-kinase inhibition improves left ventricular contractile dysfunction in early type-1 diabetes by increasing myosin cross-bridge extension.

Authors:  Mark T Waddingham; Amanda J Edgley; Alberto Astolfo; Tadakatsu Inagaki; Yutaka Fujii; Cheng-Kun Du; Dong-Yun Zhan; Hirotsugu Tsuchimochi; Naoto Yagi; Darren J Kelly; Mikiyasu Shirai; James T Pearson
Journal:  Cardiovasc Diabetol       Date:  2015-07-22       Impact factor: 9.951

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.